Publicly-traded pharmaceutical giant Roche acquired Stratos Genomics, a Seattle DNA sequencing startup, reported GeekWire.
Founded in 2007, Stratos’ technology is called Sequencing By Expansion (SBX), which converts DNA into more easily-read polymer, making it cheaper and faster to sequence DNA, according to the company.
Stratos had raised more than $60 million, according to PitchBook, including a $20 million round from Fisk Ventures in 2018. Roche was an early investor via its Roche Ventures arm.
“We look forward to further advancing our sequencing technology as we move to the next generation of healthcare and welcome the world-class scientists and employees from Stratos Genomics to Roche,” Thomas Schinecker, CEO Roche Diagnostics, said in a statement.
Terms of the deal were not disclosed. Stratos will continue operating out of Seattle under the name Roche Diagnostics Seattle. The company originally spun out of Stratos Group. It has 60 employees, according to LinkedIn. Its chairman is Lee Huntsman, a professor emeritus at the University of Washington.
“We are thrilled to join the Roche family, which will allow us to combine our unique Sequencing by Expansion chemistry with the Roche nanopore sequencer,” said Mark Kokoris, President, CEO, and co-founder at Stratos Genomics, in a statement. “With our combined expertise and complementary technologies, we are well-positioned to open the path to deliver scalable, high-performance sequencing to clinicians and researchers.”
Full Content: Geek Wire
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
French Regulator Meat-Cutting Sector Case Following Antitrust Review
May 15, 2024 by
CPI
Arizona Attorney General Files Suit Against Amazon Over Unfair Business Practices
May 15, 2024 by
CPI
Varsity Spirit and Private Equity Owners Settle Class Action Antitrust Suit
May 15, 2024 by
CPI
US Senators Present AI Strategy, Call for Funding Surge
May 15, 2024 by
CPI
Hausfeld Strengthens Competition Bench with Key Hires in London and Germany
May 15, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI